Munich, Germany

Theodor Hermann Lippert

This inventor holds 1 USPTO granted patent. Top assignee: Jenapharm Gmbh. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Theodor Hermann Lippert. Retrieved from https://idiyas.com/inventor/theodor-hermann-lippert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Theodor Hermann Lippert - Innovative Inventor from Tübingen

Introduction: Theodor Hermann Lippert is a renowned inventor hailing from Tübingen, Germany, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Lippert's recent patents include advancements in renewable energy systems, medical devices, and sustainable materials, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: With a career spanning over three decades, Lippert has established himself as a pioneer in the development of cutting-edge technologies, holding numerous patents that have significantly impacted industries worldwide.

Collaborations: Throughout his career, Lippert has collaborated with leading research institutions, universities, and multinational companies to bring his innovative ideas to life, fostering a culture of creativity and excellence in the field of invention.

Conclusion: Theodor Hermann Lippert's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and leaving a lasting impact on the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…